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T he average life expectancy has been increasing in recent years in many countries.  Japan has had the 
highest average life expectancy across the world since 
2011.  Gallbladder carcinoma (GBC) is the most com-
mon cancer of the biliary tract,  and it has a poor prog-
nosis [1].  The risk of GBC increases with age [2].  GBC 
is expected to occur at a higher rate among elderly 
patients in the future,  and the clarification of appropri-
ate treatment strategies for elderly patients with GBC is 
thus urgently needed.  Surgical treatment is the only 
effective and commonly employed treatment for GBC,  
but it is associated with high morbidity.  Although the 
quality of surgical treatment and pre-operative manage-
ment continues to improve,  the safety of surgical treat-
ment for elderly patients remains unclear.
The aims of the present study were to identify the 
characteristics of elderly patients (≥ 75 years old) who 
underwent surgical treatment for GBC and to compare 
the surgical outcomes of these patients with those of 
younger GBC patients.  We also analyzed the prognos-
tic factors that affect the overall survival of elderly GBC 
patients.
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Gallbladder carcinoma (GBC) is a common malignancy with a poor prognosis.  With the average life expec-
tancy increasing globally,  the incidence of GBC is predicted to increase as well.  We investigated the safety and 
feasibility of surgical treatment for elderly patients with GBC.  We retrospectively compared clinical pathologi-
cal data and treatment outcomes in 45 consecutive GBC patients (23 patients ≥ 75 years [elderly group] and 22 
patients < 75 years [younger group]) who underwent curative resection at the Iwakuni Center from January 
2008 to December 2017.  The proportion of preoperative comorbidities and anticoagulant use was significantly 
higher in the elderly group.  The American Society of Anesthesiologists score was higher in the elderly versus 
the younger group,  and the elderly group had significantly shorter operation times.  Reduced activities of daily 
living was more common in the elderly versus younger group.  The percentage of radical resection and overall 
3-year survival (66.6% younger vs. 64.4% elderly) were similar between the groups.  Controlling Nutritional 
Status (CONUT) score ≥ 3 and R0 resection were identified as prognostic factors for overall survival rate among 
all patients.  After careful patient selection,  surgery can be safely performed for elderly GBC patients,  with out-
comes similar to those of younger patients.
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Patients and Methods
Patients. A total of 45 consecutive GBC patients 
(25 males [55.6%] and 20 females [44.4%]) underwent 
surgical treatment at the Iwakuni Clinical Center during 
the period from January 2008 to July 2018.  The median 
age at operation was 74.5 years (range 38-95 years).  For 
this study,  patients ≥ 75 years old were classified as the 
elderly group (23 patients) and patients < 75 years old 
were classified as the younger group (22 patients).  The 
median age was 82 years (range 75-95 years) for the 
elderly group and 63 years (range 38-74 years) for the 
younger group.
We applied evidence-based clinical practice guide-
lines for the treatment of GBC.  [3 , 4].  Based on preop-
erative imaging studies and clinical data,  hepatectomy 
was indicated only in cases in which sufficient hepatic 
function would have been conserved post-surgery.  
According to incidental GBC,  we used reported treat-
ment strategies [5].  The pre-operative data included 
gender,  age,  body mass index,  smoking history,  
drinking history,  associated diseases (hypertension,  
diabetes,  cardiac disease,  stroke),  the American Society 
of Anesthesiologists (ASA) Physical Status Score,  and 
the Controlling Nutritional Status (CONUT) score [6].  
The post-operative clinicopathological data included the 
surgical procedure,  blood loss,  operative time,  and 
tumor stage per the Union for International Cancer 
Control (UICC) classification.  Treatment results 
included complications and disease-free and overall 
survival.
This was a retrospective cohort study conducted to 
identify the clinical characteristics and surgical out-
comes of elderly GBC patients.  Patients were not 
required to give informed consent to the study,  because 
the analysis used anonymous data that were obtained 
after patient agreed to treatment by written consent.  
The ethics committee at the Iwakuni Clinical Center 
approved the study protocol.  This study was performed 
in accordance with the 1975 Declaration of Helsinki.
Surveillance. Each patient’s follow-up duration 
was calculated from the day of surgery to either the day 
of death or the day of the last follow-up visit.  The 
median follow-up duration was 35 months (range 3-102 
months).  All patients were followed-up at least every 3 
months in the first year post-surgery and at intervals of 
3-6 months thereafter.  Abdominal ultrasonography and 
computed tomography were performed during the fol-
low-up period at intervals of 3 months and 6 months,  
respectively.
Statistical methods. Statistical analyses were per-
formed using the unpaired Student’s t-test and the chi-
square test with Fisher’s exact test.  Survival rates were 
calculated using the Kaplan-Meier method and were 
compared using the log-rank test.  The duration of dis-
ease-free survival was calculated based on either death 
or GBC recurrence as the terminal event.  We per-
formed a multivariate analysis of prognostic factors 
using Cox proportional hazard modeling.  A p-value 
< 0.05 was considered significant.  The statistical analy-
ses were undertaken using JMP ver. 9 software (SAS 
Institute,  Cary,  NC,  USA).
Results
The elderly and younger patients’ pre-operative clin-
icopathological factors are summarized in Table 1.  The 
proportion of preoperative comorbidities and anticoag-
ulant use was significantly higher in the elderly group 
compared to the younger group (p-value was respec-
tively 0.02).  The ASA scores were significantly higher in 
the elderly group compared to the younger group 
(p = 0.05).  There was a greater number of patients with 
pancreatobiliary malfunction in the younger group than 
in the elderly group.  The body mass index values and 
CONUT score did not differ significantly between the 
groups.
The two patient groups’ tumor characteristics and 
intra- or post-operative data are shown in Table 2.  The 
elderly group had significantly shorter operation times 
compared to the younger group.  The blood loss during 
surgery in the elderly group was less than that in the 
younger group,  though not significantly.  There was no 
significant difference in the type of hepatectomy or the 
incidence of blood transfusion between the patient 
groups.  The percentage of radical resection was not 
significantly different between the groups (68.2% for the 
younger group vs. 82.6% for the elderly group).
The elderly patients showed a significantly higher 
incidence of decline in the level of activities of daily liv-
ing (ADL) after surgery compared to the younger 
patients (p = 0.01).  There was no significant between-
group difference in the postoperative complication rate,  
length of postoperative hospital stay,  postoperative 
delirium,  or decrease in serum albumin levels at 3 
months after surgery.  Based on the patients’ tumor 
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characteristics and the classification guidelines,  there 
was no significant difference in tumor size,  lymph node 
metastasis,  staging,  or tumor differentiation between 
the 2 groups.
There was no significant difference in the distribu-
tion of the cause of death between the two groups.  
There was one case of death unrelated to GBC in the 
elderly group.  The patient died from panperitonitis 
caused by duodenal perforation after an endoscopic 
sphincterotomy.  There were four cases of death unre-
lated to GBC in the younger group: primary lung can-
cer,  pneumonia,  acute myocardial infarction,  and an 
unknown cause.  The operative mortality rate was 2.2% 
(1 patient),  and this patient (in the younger group) died 
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????? ?　 Patient background in the elderly (≥75 years) and younger (＜75 years) patients with GBC
Characteristic Elderly (n＝23) Younger (n＝22) p-value
Male/female 12/11 14/8 0.36
Age,  years (range) 82 (75-95) 63 (38-74) ＜0.01
BMI 20.3±4.3 22.4±3.1 0.10
Smoking history 8 (34.8%) 10 (45.5%) 0.54
Drinking history 7 (30.4%) 9 (40.9%) 0.53
Co-morbidities: 17 (73.9%) 9 (40.9%) 0.02
　Diabetes mellitus 3 (13.0%) 4 (18.2%) 0.63
　Hypertension 10 (43.5%) 5 (22.7%) 0.14
　Cardiac disease 3 (13.0%) 3 (13.6%) 0.95
　Stroke 6 (26.1%) 2 (9.1%) 0.13
Use of anticoagulant 9 (38.1%) 3 (13.6%) 0.02
Pancreaticobiliary maljunction 2 (8.7%) 8 (36.4%) 0.03
ASA score ≥3 9 (39.1%) 3 (13.6%) 0.05
CONUT score ≥3 9 (39.1%) 7 (31.8%) 0.53
ASA,  American Society of Anesthesiologists; BMI,  body mass index; CONUT,  Controlling Nutritional Status.
????? ?　 Intra- and post-operative data and tumor characteristics
Factor Elderly (n＝23) Younger (n＝22) p-value
Intraoperative factors:
　Operative time,  min (range) 299 (145-397) 358 (300-785) 0.03
　Blood loss,  ml 398±125 640±168 0.07
　Blood transfusion 5 (21.7%) 4 (18.2%) 0.94
　Hepatectomy 16 (69.6%) 17 (77.3%) 0.56
　R0 (radical resection) 19 (82.6%) 15 (68.2%) 0.26
Postoperative factors:
 Complications: (Clavien-Dindo grade ≥ II) 8 (34.8%) 7 (31.8%) 0.83
　 Delirium 5 (21.7%) 1 (4.6%) 0.07
　 Hospital stay,  median (range) 13 (4-63) 11.5 (4-50) 0.71
　 Decline in ADL level 5 (21.7%) 0 (0%) 0.01
　 Alb level 3 mos.  post-surgery 5 (21.7%) 2 (10.0%) 0.26
 Tumor characteristics:
　 Tumor size (cm) 3.75±1.9 5.1±2.9 0.27
　 Tumor depth; T1/T2/T3/T4 2/16/4/1 8/6/5/3 0.03
　 Lymph node metastasis 7 (30.4%) 7 (31.8%) 0.92
　 Stage UICC6th (I/II/IIA/IIIB/IVA/IVB) 2/12/1/7/1/0 8/6/2/3/2/1 0.07
 Tumor diﬀerentiation (pap/well/mod/poor/asc/aec) 8/7/4/3/0/1 6/11/2/0/2/1 0.28
ADL,  activity of daily living;  aec,  adenoendocrine carcinoma; Alb,  albumin; asc,  adenosquamous carcinoma; mod,  moderately diﬀeren-
tiated; pap,  papillary adenocarcinoma; poor,  poorly diﬀerentiated; UICC,  Union for International Cancer Control; well,  well diﬀerenti-
ated.
of liver failure secondary to embolization of the hepatic 
artery for abdominal bleeding due to a pseudo- aneu-
rysm rupture.
Overall survival rates post-surgery for the elderly 
group at 1 , 2,  and 3 years were 95.5%,  77.6%,  and 
64.4%,  respectively,  whereas those for the younger 
group were 81.8%,  72.2%,  and 66.6%,  respectively 
(Fig. 1).  Disease-free survival rates post-surgery for the 
elderly group at 1 , 2,  and 3 years were 81.8%,  55.3% 
and 55.3%,  and those for the younger group were 
68.2%,  68.2%,  and 62.3%,  respectively (Fig. 2).  There 
were no significant differences in the overall survival 
rates or disease-free survival rates between the 2 groups.
The prognostic factors for the overall survival rate 
among all patients are shown in Table 3.  A CONUT 
score ≥ 3 (odds ratio [OR] = 4.69,  p=0.007) and the use 
of radical resection (OR= 7.12,  p< 0.001) were identified 
as the significant prognostic factors according to the 
multivariate analysis.  Age was not identified as a signif-
icant prognostic factor.
Discussion
The results of our present analyses demonstrated no 
significant difference in the post-operative complication 
rates or long-term survival between the elderly and 
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Number at risk
Log-rank test P=0.86
Elderly 
Younger
(day)
Elderly 
Younger
23 21 16 13 8 4 2
22 18 16 15 13 12 9
100.0%
80.0%
60.0%
40.0%
20.0%
0.0%
0 500 1,000 1,500
???? ?　 Overall survival rates post-surgery for the elderly group (n
＝23,  thick line) and younger group (n＝22,  dotted line).  There 
was no signiﬁcant diﬀerence in the overall survival rate between the 
2 groups.
Log-rank test P=0.82
Number at risk
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Younger
(day)
Elderly 
Younger
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???? ?　 Disease-free survival rates post-surgery for the elderly 
group (n＝23,  thick line) and younger group (n＝22,  dotted line).  
There was no signiﬁcant diﬀerence in the disease-free survival rate 
between the 2 groups.
????? ?　 Univariate and multivariate analysis of factors related to the overall survival rate for all patients
Factor Univariate p-value Multivariate p-value Odds ratio (95%CI)
Gender 0.80
Elderly age,  ≥75 years 0.85
Use of anticoagulant,  yes/no 0.60
Smoking history,  yes/no 0.05
Drinking history,  yes/no 0.11
Associated disease,  yes/no 0.10
ASA score ≥3 0.38
CONUT score＊ ≥3 0.005 0.007 4.69 (1.5-15.1)
Radical resection,  yes/no ＜0.001 ＜0.001 7.12 (2.4-23.6)
Operative time ≥300 min 0.95
Blood loss ≥500 ml 0.33
Blood transfusion,  yes/no ＜0.001
Stage ≥3,  UICC 6th ＜0.001
younger patients with GBC,  although the elderly 
patients had more associated co-morbidities.  These 
results indicate that advanced age alone should not be a 
contraindication to surgical treatment for GBC.
Varying clinical outcomes have been reported for 
elderly patients undergoing surgical treatment for hepa-
to-pancreato-biliary cancer [7-13].  Several research 
groups have proposed advanced age as a risk factor 
associated with increased post-operative complications 
and mortality [8 , 9 , 11 , 12],  but other studies have 
shown no increased risk associated with advanced age 
[7 , 10 , 13].  Surgical treatment remains the curative 
therapy of choice for hepato-pancreato-biliary cancer 
for patients of all ages,  but the use of surgical treatment 
for elderly patients thus remains controversial.
In the present study,  the elderly patients had shorter 
operative times and less blood loss compared to the 
younger patients,  though the difference was not signif-
icant.  The surgery performed for the elderly patients 
was generally minimally invasive,  e.g.,  selective lymph 
node dissection.  However,  the surgical outcomes (i.e.,  
the morbidity,  overall survival,  and disease-free sur-
vival rates) were not significantly different between the 
elderly and younger groups.  For elderly patients there-
fore,  aggressive surgery should be avoided and mini-
mally invasive surgery with curability should be per-
formed.
In the present analyses,  the elderly patients showed 
a higher incidence of decline in ADL level after surgery 
compared to the younger patients,  although the surger-
ies in the elderly patients were minimally invasive.  The 
decline in ADL level may be unavoidable,  because 
elderly patients have a lower physiologic reserve than 
younger patients.  Moreover,  the decline is more likely 
to be related to the higher incidence of co-morbidities 
in elderly patients.
An enhanced recovery after surgery (ERAS) pro-
gram was recently reported to be safe and to contribute 
to decreased total complication rates and hospital stays 
in hepatobiliary area [14 , 15].  The underlying principle 
of the ERAS program is a multimodal perioperative 
protocol designed to attenuate the inflammatory 
response and potentiate patient rehabilitation after sur-
gery [16 , 17].  The adaptation of the ERAS program 
might be effective in elderly patients to prevent a 
post-surgery decline in ADL.
Our present findings demonstrated that a CONUT 
score ≥ 3 was an independent prognostic risk factor in 
patients with GBC who underwent surgery.  The prog-
nostic significance of the CONUT score in patients with 
colorectal cancer or hepatocellular carcinoma has been 
reported [18-20].  The CONUT score is a screening tool 
designed to easily and objectively assess patients’ nutri-
tional status [6].  The CONUT score is derived from 
serum concentrations of albumin,  total cholesterol,  
and the total lymphocyte count.  These three parameters 
are markers of protein reserves,  impaired immune 
defenses,  and caloric depletion,  respectively.  The 
CONUT score thus represents three important immu-
nonutritional indices.  Preoperative immunonutrition is 
reported to be beneficial in reducing overall and infec-
tious postoperative complications [21 , 22].  We there-
fore recommend the perioperative administration of 
immunonutrition in patients with a high CONUT 
score,  as doing so may improve the prognoses of these 
patients.
This study has limitations including its very small 
sample size (n = 45),  single-institute analysis,  patient 
selection bias,  absence of long-term follow-up,  and the 
inherent nature of a retrospective study.  Nevertheless,  
our experience shows that with careful pre-operative 
planning that includes minimally invasive surgery with 
curability and postoperative care,  surgery for GBC can 
be safe for elderly patients.  Additional studies are 
needed to address remaining aspects including the 
characteristics of patients for whom surgery is contrain-
dicated.
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